Rosetta Receives 2 Patent Allowances, 1 for Mesothelioma Diagnostic
News
Rosetta Genomics, a company that develops microRNA-based diagnostics, has added two new patent allowances to its intellectual property. A patent allowance is issued by a regulatory entity (U.S. Patent and ... Read more